This list is an analysis based on recent market events. It's not an investment recommendation.
Hexima Limited is a biotechnology firm focused on the discovery and advancement of plant-derived proteins and peptides for medical applications in humans. Its primary drug candidate, pezadeftide, a plant defensin, is presently undergoing Phase IIb clinical evaluations in Australia and New Zealand to address fungal toenail infections. The company was established in 1997 and its main operations are situated in Preston, Australia.
Show more...
FAQ
What is Hexima Limited. stock price today?▼
The current price of HXL.AU is A$0.05 AUD — it has increased by +0% in the past 24 hours. Watch Hexima Limited. stock price performance more closely on the chart.
What is Hexima Limited. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Hexima Limited. stocks are traded under the ticker HXL.AU.
What is Hexima Limited. market cap?▼
Today Hexima Limited. has the market capitalization of 8.69M
What is Hexima Limited. revenue for the last year?▼
Hexima Limited. revenue for the last year amounts to 0 AUD.
What is Hexima Limited. net income for the last year?▼
HXL.AU net income for the last year is -504,000 AUD.
Does Hexima Limited. pay dividends?▼
Yes, HXL.AU dividends are paid en. The last dividend per share was 0.02 AUD. As of today, Dividend Yield (FWD)% is 92.31%.
In which sector is Hexima Limited. located?▼
Hexima Limited. operates in the Health & Wellness sector.
When did Hexima Limited. complete a stock split?▼
The last stock split for Hexima Limited. was on April 21, 2026 with a ratio of 1:4.
Where is Hexima Limited. headquartered?▼
Hexima Limited. is headquartered in Carlton, Australia.